Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), Defibtech, and the Professional Football Athletic Trainers Society Foundation Inc. (PFATS Foundation), are coming together to donate and distribute automated external defibrillators (AEDs). Recognizing…
Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today released its 2023 State of Telemedicine Report, revealing that nearly 88% of U.S. physicians surveyed believe telemedicine has…
More than 2,800 attendees including pharmacists, independent pharmacy owners, technicians, exhibitors and McKesson experts came together last week at the 2023 McKesson ideaShare conference in Las Vegas. The annual event, which is…
Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the U.S. Food and Drug Administration (FDA) has approved NGENLA (somatrogon-ghla), a once-weekly, human growth hormone analog…
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s Biologics License Application (BLA) for fidanacogene elaparvovec for the treatment of adults with…
The company will showcase its latest innovative solutions to enable rapid diagnosis, Theranostics, and precision care at #SNMMI23 CHICAGO — At the Society of Nuclear Medicine and Molecular Imaging (SNMMI)…
Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), today announced its presence at the 26th annual First There First Care – Gathering of Eagles Conference from June 12 through June 16…
A leading global life sciences company, today announced that Fortrea Holdings Inc., a wholly owned subsidiary of Labcorp (“Fortrea”), has launched an offering of senior secured notes due 2030 (the “Notes”), subject to…
A leading global life sciences company, today announced the appointment of Dr. Paul Rothman to its Board of Directors as an independent member. Dr. Rothman’s appointment is effective June 6, 2023, at which time the…
MWI Animal Health, a part of AmerisourceBergen and a leading distributor of animal health products, today unveiled an updated and expanded version of its pet wellness web and mobile application…
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has approved a new indication for PREVYMIS® (letermovir) for…
a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced distant metastasis-free survival (DMFS) results from the Phase…